Compounds > n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine
Page last updated: 2024-09-03

n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and scopolamine hydrobromide

n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine has been researched along with scopolamine hydrobromide in 1 studies

Compound Research Comparison

Studies
(n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)		Trials
(n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)		Recent Studies (post-2010)
(n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)		Studies
(scopolamine hydrobromide)		Trials
(scopolamine hydrobromide)		Recent Studies (post-2010) (scopolamine hydrobromide)
2145587,5485631,401

Protein Interaction Comparison

ProteinTaxonomyn(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine (IC50)scopolamine hydrobromide (IC50)
Muscarinic acetylcholine receptor M4Homo sapiens (human)0.003
Muscarinic acetylcholine receptor M1Rattus norvegicus (Norway rat)0.006
Muscarinic acetylcholine receptor M3Rattus norvegicus (Norway rat)0.006
Muscarinic acetylcholine receptor M4Rattus norvegicus (Norway rat)0.006
Cytochrome P450 3A4Homo sapiens (human)0.0006
Muscarinic acetylcholine receptor M5Rattus norvegicus (Norway rat)0.006
Muscarinic acetylcholine receptor M2Rattus norvegicus (Norway rat)0.006
Muscarinic acetylcholine receptor M1Homo sapiens (human)0.0026

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rubaj, A; Sieklucka-Dziuba, M; Zgodziński, W1

Other Studies

1 other study(ies) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and scopolamine hydrobromide

ArticleYear
The influence of adenosine A3 receptor agonist: IB-MECA, on scopolamine- and MK-801-induced memory impairment.
    Behavioural brain research, 2003, Apr-17, Volume: 141, Issue:1

    Topics: Adenosine; Animals; Avoidance Learning; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Maze Learning; Memory; Memory Disorders; Mice; Motor Activity; Muscarinic Antagonists; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A3; Scopolamine; Theophylline

2003